LJPC
La Jolla Pharmaceutical Company
LJPC
LJPC
Delisted
LJPC was delisted on the 19th of August, 2022.
76 hedge funds and large institutions have $88.1M invested in La Jolla Pharmaceutical Company in 2021 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 16 increasing their positions, 22 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
27% less repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 22
61% less call options, than puts
Call options by funds: $114K | Put options by funds: $294K
Holders
76
Holding in Top 10
2
Calls
$114K
Puts
$294K
Top Buyers
| 1 | +$1.47M | |
| 2 | +$1.34M | |
| 3 | +$1.1M | |
| 4 |
Millennium Management
New York
|
+$746K |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$487K |
Top Sellers
| 1 | -$2.08M | |
| 2 | -$407K | |
| 3 | -$295K | |
| 4 |
RI
RTW Investments
New York
|
-$295K |
| 5 |
FMBTD
First Midwest Bank Trust Division
Joliet,
Illinois
|
-$282K |